Non-A, non-B hepatitis: impact of the emergence of the hepatitis C virus.
Hsia
P C
PC
Veterans Affairs Medical Center, Georgetown University School of Medicine, Washington, D.C.
Seeff
L B
LB
D004196:Disease Outbreaks; D016174:Hepacivirus / Q000302:isolation & purification*; D006508:Hepatitis Antibodies / Q000032:analysis; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D015995:Prevalence; D011994:Recombinant Proteins; D014481:United States / Q000453:epidemiology
D006508:Hepatitis Antibodies; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins